KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $2,638,000 | -25.7% | 264,297 | -5.2% | 1.67% | -18.9% |
| Q1 2015 | $3,550,000 | +375.2% | 278,885 | +428.6% | 2.06% | +340.0% |
| Q4 2014 | $747,000 | -3.4% | 52,758 | -6.1% | 0.47% | +9.3% |
| Q3 2014 | $773,000 | +69.1% | 56,192 | +89.1% | 0.43% | +82.1% |
| Q2 2014 | $457,000 | -12.1% | 29,709 | -2.6% | 0.24% | -8.9% |
| Q1 2014 | $520,000 | – | 30,501 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |